Related Experiment Video
Updated: May 15, 2025
Conducting Maximal and Submaximal Endurance Exercise Testing to Measure Physiological and Biological Responses to Acute Exercise in Humans
Published on: October 17, 2018
Understanding pharmacists' engagement in sport and exercise medicine, including pharmacist-physiotherapist
Alison D Hooper1, Jodie Marquez2, Beata Bajorek1
1School of Biomedical Sciences & Pharmacy, College of Health, Medicine & Wellbeing, University of Newcastle, Callaghan, NSW, Australia.
Background:
Sport and exercise medicine (SEM) is a multidisciplinary field that integrates expertise from various healthcare professionals to optimise athletic performance and promote physical activity for chronic disease prevention and management. Australian pharmacists are well-positioned to contribute to SEM, yet their roles remain undefined beyond niche areas like anti-doping. Interdisciplinary collaboration, particularly with physiotherapists, is also underexplored. This study investigates pharmacists' engagement in SEM and pharmacist-physiotherapist collaboration, using the Capability, Opportunity, Motivation-Behaviour (COM-B) model to explore behavioural components.
Methods:
A qualitative study was conducted using semi-structured interviews with 14 Australian pharmacists practicing across diverse settings. Data were thematically analysed and mapped to the COM-B framework.
Results:
Five key themes emerged: (1) Broad scope of pharmacy practice in SEM incorporating both pharmacological and non-pharmacological advice; (2) Opportunities and challenges in inter-professional collaboration, constrained by informal referral pathways and limited interdisciplinary communication (3) Gaps in SEM-related training and education, with pharmacists expressing interest in targeted professional development; (4) Perceived barriers to engagement, including time constraints, remuneration issues and lack of professional recognition; and (5) Future opportunities for pharmacists in SEM, such as integration into multidisciplinary SEM teams and supporting physiotherapist prescribing.
Conclusions:
Pharmacists are well-placed to play a broader role in SEM but face systemic and educational barriers. Enhancing training, establishing formal referral and interdisciplinary communication pathways and addressing structural challenges could improve engagement. This study lays the groundwork for future interventions to enhance pharmacists' contributions to SEM and strengthen pharmacist-physiotherapist collaboration, ultimately improving consumer care and health outcomes.
More Related Videos
06:52An Inertial Measurement Unit Based Method to Estimate Hip and Knee Joint Kinematics in Team Sport Athletes on the Field
Published on: May 26, 2020
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
Related Concept Videos
01:28Biopharmaceutics and Pharmacokinetics: Overview
01:18Interdisciplinary Care: The Health Care Team-II
Physical Therapist
A physical therapist (PT) aims to restore function or prevent additional impairment in a patient following an injury or disease. Massage, heat, cold, water, sonar waves, exercises, and electrical stimulation are some treatments used by PTs to treat...
01:15Model Approaches for Pharmacokinetic Data: Physiological Models
01:21Pharmacodynamics: Overview and Principles
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
01:13Physiological Pharmacokinetic Models: Assumption with Protein Binding
01:23Factors Affecting Protein-Drug Binding: Drug Interactions
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...